Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroma × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 51 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Lymphoma 42 Burkitt Lymphoma 34 Lymphoma, Follicular 31 Myelodysplastic Syndromes 30 Lymphoma, Non-Hodgkin 30 Lymphoma, Large B-Cell, Diffuse 30 Multiple Myeloma 28 Leukemia, Myeloid, Acute 27 Leukemia, Myeloid, Chronic-Phase 26 Leukemia, Myeloid, Accelerated Phase 24 Lymphoma, Large-Cell, Immunoblastic 23 Leukemia, Lymphocytic, Chronic, B-Cell 23 Blast Crisis 20 Graft vs Host Disease 19 Neoplasms, Plasma Cell 18 Myeloproliferative Disorders 18 Hodgkin Disease 18 Dendritic Cell Sarcoma, Interdigitating 18 Recurrence 17 Lymphoma, Mantle-Cell 17 Lymphoma, B-Cell, Marginal Zone 17 Leukemia, Myelomonocytic, Chronic 15 Leukemia, Biphenotypic, Acute 15 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 13 Congenital Abnormalities 13 Primary Myelofibrosis 12 Anemia, Refractory, with Excess of Blasts 12 Myelodysplastic-Myeloproliferative Diseases 11

Interventions

Bupivacaine 2 Therapeutics 1 Sodium Chloride 1 Ralfinamide 1 Musculoskeletal Manipulations 1 Methylprednisolone 1 Lidocaine 1 Indocyanine Green 1 Dry Needling 1 Decompression 1 Cholecalciferol 1 Bevacizumab 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02304094 2016-03-29

Morton's Neuroma: Manipulation Versus Steroid Injection

Queen Margaret University

Phase NA Unknown

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡